GET THE APP

Peptide nucleic acid: Current perspectives and application f | 16517
International Research Journals
Reach Us +44 330 818 7254

International Research Journal of Pharmacy and Pharmacology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Peptide nucleic acid: Current perspectives and application for future therapeutics

Abstract

Manoj G Tyagi

Peptide nucleic acid (PNA) is a deoxyribonucleic acid (DNA) mimic based on a polyamide backbone first synthesized and reported by Peter Nielsen in 1991. PNA shows remarkable hybridization properties and has many exciting applications. It is chemically and biologicaly stable and can readily conjugate with peptides and other useful molecules. The search for new chemical modification of the PNA is a very active field of research and new structures are continuosly proposed. Conjugation of an oligonucleotide to some peptides that can move through the cell membrane would facilitate the passage of this conjugate across for delivery into the cell’s cytosol. Oligonucleotides can also be conjugated to lipids to yield derivatives with lipophilic properties that are capable to pass across the cell membrane. Thus, PNA can have multiple roles to perform in molecular biology, antigene therapy, molecular diagnostics and nano-biotechnology.

Share this article